期刊文献+

结直肠癌淋巴结微转移的临床研究 被引量:2

Clinical study on lymph node micrometastasis of colorectal cancer
原文传递
导出
摘要 目的探讨结直肠前哨淋巴结(SLN)的定位方法及检测淋巴结微转移的有效方法,并分析其临床意义。方法对60例结直肠癌患者采用亚甲蓝染色法淋巴结示踪,寻找染色的SLN,切除后的SLN行HE染色和细胞角蛋白CK20免疫组化检测;并与前期直接行淋巴结清扫的60例患者对比。结果亚甲蓝组中可识别SLN者54例(90.0%),高于前期直接清扫组的24例(40.0%)(P<0.05);54例中行常规HE染色检出36例阳性,18例阴性。18例SLN阴性者行免疫组化检测,6例(33.3%)检出有微转移灶。结论联合应用亚甲蓝和细胞角蛋白CK20进行结直肠癌SLN定位优于单用其中之一种方法;免疫组化是检测淋巴结微转移的敏感方法。 Objective To study the mothods in detecting sentinel lymph node (SLN) and lymph node micrometastasis in patients with colorectal cancer and their clinical significance. Methods Sixty patients with colorectal cancer undergoing lymphatic mapping using methylene blue staining ( group Ⅰ ) was analysed. The SLN was identified and removed, and the micro-metastases in sentinel lymph node were detected with HE and immunohistochemical staining technique. Other sixty patients previously treated by direct radical lymphadenectomy were taken as comtrol group (gronp Ⅱ). Results Fifty-four SLN were successfully identifed in group I, with a detection rate of 90.0% , which was higher than that of control group (24/60,40%) ( P 〈 0.05 ) ; in group Ⅰ, thirty-six positive SLN were dectected by HE staining, and six micro-metastases (33.3%) were found in eighteen negative SLN by use of Cytokeratin 20 immuno-histochemical staining. Conclusions The success rate achieved by combining methylene blue staining and cytokeratin 20 immunohistochemical staining in detecting SLN and lymph node microstasis is higher than that achieved by using either technique mentioned above alone.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2009年第10期1043-1045,共3页 China Journal of General Surgery
关键词 结直肠肿瘤 淋巴结微转移 细胞角蛋白 Colorectal Neoplasms Lymph Node Micrometastasis Cytokeratin20
  • 相关文献

参考文献9

二级参考文献55

共引文献39

同被引文献27

  • 1牟江洪,阎晓初,李增鹏,王东,段光杰,向德兵,肖华亮,张沁宏.结直肠癌淋巴管生成的特点及其临床病理意义[J].中华病理学杂志,2005,34(6):348-352. 被引量:39
  • 2Appelbaum FR. Haematopoietic cell transplantation as immunotherapy[J]. Nature, 2001, 411 (6835) :385 -389. 被引量:1
  • 3Bregni M, Bemardi M, Ciceri F, et al. Allogeneic stem cell transplantation for the treatment of advanced solid tumors [ J ] . Springer Semin Immunopathol, 2004, 26 ( 1 - 2 ) : 95 -108. 被引量:1
  • 4Holen KD, Saltz LB. New therapies, new directions : advances in the systemic treatment of metastatic eolorectal cancer [ J ]. Lancet Oneol, 2001, 2(5) :290-297. 被引量:1
  • 5Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [ J ] . N Engl J Med, 2004, 351 (4) :337 -345. 被引量:1
  • 6Saltz LB, Meropol N J, Loehrer PJ Sr, et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor [ J ]. J Clin Oncol,2004,22(7) :1201 - 1208. 被引量:1
  • 7Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[ J]. N Engl J Med, 2004 , 350 ( 23 ) : 2335 -2342. 被引量:1
  • 8Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acule graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation[J]. Blood, 2000, 95(9) :2754 -2759. 被引量:1
  • 9Hambach L, Gouhny E. Immunotherapy of cancer through targeting of minor histocompatibility antigens [ J ] . CurrOpin Immunol, 2005, 17(2) :202 -210. 被引量:1
  • 10Molldrem JJ, Lee PP, Wang C, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia [ J ] . Nat Med, 2000, 6 : 1018 - 1023. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部